Drug Database
Back to search

Switzerland· 54756038

Fluoresceine Oxybuprocaine SDU Faure, Augentropfen

A fluorescein, kombinationen product containing fluoresceinum natricum, oxybuprocaini hydrochloridum, registered in Switzerland by OmniVision AG and dispensed under Swissmedic category B. The same ATC class is registered in 7 of our 19 countries.

Cat B (Swissmedic)ATC S01JA51

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedFluoresceine Oxybuprocaine SDU Faure,…ATCS01JA51REGISTER NO.54756038PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluoresceinum natricum, oxybuprocaini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fluorescein, kombinationen is registered in 7 of 19 countries.

Countries holding a registration under ATC S01JA51 (fluorescein, kombinationen), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 4 of them publish a price we can compare per daily dose
Search fluorescein, kombinationen products by name

Fluorescein, kombinationen · ATC S01JA51

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
fluoresceinum natricum, oxybuprocaini hydrochloridum
Manufacturer
OmniVision AG
Country
Switzerland (CH)
ATC code
S01JA51
ATC class
Fluorescein, Kombinationen
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluorescein, kombinationen in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluorescein, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Belgium · Combiflure
  • Germany · Thilorbin
  • Denmark · Combiflure
  • Finland · Oftan Flurekain
  • Italy · Flurekain
  • Luxembourg · Combiflure, Thilorbin
  • Norway · Combiflure
  • Portugal · Fluotest Multidose
  • Sweden · Optax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa9ae6a0-8935-4530-8a3c-6579457387fa
GET /v1/drugs/fa9ae6a0-8935-4530-8a3c-6579457387fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about fluorescein, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console